从YAHOO搬个帖子过来，关心BNGO的可以进来看看

来源: imnotarobot 于 2021-01-28 18:29:56 [档案] [旧帖] [给我悄悄话] 本文已被阅读：次 (10815 bytes)

Excellent Reddit thread worth reading
For the past three weeks I have been only trading BNGO and only researching the company Bionano Genomics. These are just some of my thoughts:

BNGO- [ many catalysts to come - possible Mad Money TV show appearance, FDA approval, more news of institutional ownership and currently wrapping of Festival of Genomics in Europe. Currently trading under $11 with a $14 price target from a top 100 wall street analyst in Jason McCarthy - who held a buy rating throughout BNGO's ticker existence.]

[Volume Profiling- See around August 12 Volume for PACB and stock price compared to December 29th for BNGO. Right now BNGO needs AWARENESS, similar to every gene stock, to explode].

I believe these dates and massive rise in volume set the tone for these stocks.

$BNGO in my mind will achieve what PACB did as my conservative prediction and it could break $100 this year as a strong bull case / going to the moon as Chief Medic Officer Alka Chaubey aspire Saphyr to be the first in line testing for cancer and diseases.

Combination of having THE BEST technology/product along with reducing costs, exploding genomic sector and an increasing need for funding/better treatment due to diseases (especially COVID) will drive this stock forward in 2021.

From having roughly 12 million in cash to over 300 million in cash, BNGO may be looking to open their own CLIA certified Lab in San Diego to be able to receive human tissue for testing ( will be entering a $16 billion market to compete with DGX ).

Ark Invest just posted their Big Ideas for 2021 and on page 93 recognized Bionano Genomics as the optical genome mapping company and it should be noted virtually every company on that page Ark has invested in at one point or another.

BNGO is not a direct competitor to PACB but I believe they can follow a similar price action, however, if BNGO can pull through with the nanonozzle device and dip into the long-read sequencing market then they will be competitors.

That is also not mentioning all the devices that Saphyr would be making obsolete.

So having competition with DGX and PACB will be great for BNGO along with having a product that has no real competition at the moment.

I do expect BNGO to maintain its bullish uptrend and not stray to far below the 20MA

PS ( I will be trading/investing only BNGO for the foreseeable future. I was inspired by Oliver Velez and he mentions how the best of the best trade only a few stocks. I wish to be the best of the best [ like market makers at big time firms] as far as trading goes so I chose to do it on this genetic stock as it has given me the ultimate conviction for long term GAINS )

https://preview.redd.it/sgl94c1vo0e61.png?width=1029&format=png&auto=webp&s=698ff81f5d407bf4e8d8780e4ccc9abe38e08500